Review
Published on 05 Nov 2020
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities
in Cancer Immunity and Immunotherapy

- 24,611 views
- 123 citations
Review
Published on 05 Nov 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 05 Nov 2020
in Primary Immunodeficiencies

Original Research
Published on 04 Nov 2020
in Vaccines and Molecular Therapeutics

Original Research
Published on 04 Nov 2020
in Vaccines and Molecular Therapeutics

Editorial
Published on 04 Nov 2020
in Cytokines and Soluble Mediators in Immunity
Mini Review
Published on 04 Nov 2020
in Inflammation

Original Research
Published on 04 Nov 2020
in Vaccines and Molecular Therapeutics

Methods
Published on 04 Nov 2020
in Vaccines and Molecular Therapeutics

Editorial
Published on 04 Nov 2020
in Microbial Immunology
Original Research
Published on 04 Nov 2020
in Inflammation

Case Report
Published on 03 Nov 2020
in Molecular Innate Immunity

Review
Published on 03 Nov 2020
in Cancer Immunity and Immunotherapy

Review
Published on 03 Nov 2020
in Immunological Tolerance and Regulation

Original Research
Published on 03 Nov 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 03 Nov 2020
in Microbial Immunology

Mini Review
Published on 03 Nov 2020
in Cytokines and Soluble Mediators in Immunity
